Dextromethorphan and guaifenesin use need to be monitored cautiously in patients with "poor metabolizer" CYP2D6 enzyme ranges and patients who will be sedated. This mixture medication has a huge median harmful dose (TD50) to median effective dose (ED50) ratio (or therapeutic index) in these individuals. Should your health practitioner directs https://bookmarkusers.com/story18026629/about-buy-dextromethorphan-dxm-online